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Arterial waveform parameters in a large, population-based
sample of adults: relationships with ethnicity and lifestyle
factors
JD Sluyter1, AD Hughes2, SAMcG Thom3, A Lowe4, CA Camargo Jr5, B Hametner6, S Wassertheurer6, KH Parker7 and RKR Scragg1
Little is known about how aortic waveform parameters vary with ethnicity and lifestyle factors. We investigated these issues in a
large, population-based sample. We carried out a cross-sectional analysis of 4798 men and women, aged 50–84 years from
Auckland, New Zealand. Participants were 3961 European, 321 Paciﬁc, 266 Maori and 250 South Asian people. We assessed
modiﬁable lifestyle factors via questionnaires, and measured body mass index (BMI) and brachial blood pressure (BP). Suprasystolic
oscillometry was used to derive aortic pressure, from which several haemodynamic parameters were calculated. Heavy alcohol
consumption and BMI were positively related to most waveform parameters. Current smokers had higher levels of aortic
augmentation index than non-smokers (difference = 3.7%, Po0.0001). Aortic waveform parameters, controlling for demographics,
antihypertensives, diabetes and cardiovascular disease (CVD), were higher in non-Europeans than in Europeans. Further adjustment
for brachial BP or lifestyle factors (particularly BMI) reduced many differences but several remained. Despite even further
adjustment for mean arterial pressure, pulse rate, height and total:high-density lipoprotein cholesterol, compared with Europeans,
South Asians had higher levels of all measured aortic waveform parameters (for example, for backward pressure amplitude:
β= 1.5 mm Hg; Po0.0001), whereas Paciﬁc people had 9% higher loge (excess pressure integral) (Po0.0001). In conclusion, aortic
waveform parameters varied with ethnicity in line with the greater prevalence of CVD among non-white populations. Generally, this
was true even after accounting for brachial BP, suggesting that waveform parameters may have increased usefulness in capturing
ethnic variations in cardiovascular risk. Heavy alcohol consumption, smoking and especially BMI may partially contribute to
elevated levels of these parameters.
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INTRODUCTION
Cardiovascular disease (CVD) prevalence is increased in
Polynesian and South Asian people relative to white/European
populations.1–4 This may be mediated by ethnic differences in
blood pressure (BP) and other arterially related parameters and, as
the latter may be clinically important,5–7 interventions directed at
improving arterial function might reduce these CVD disparities.
In addition, an understanding of ethnic variations in arterial
function may help to identify the population groups to be
targeted in public health interventions.
New methods8 have expanded the scope of measurable
variables from the aortic pressure waveform such as aortic BP,
augmentation index (Alx), backward pressure (Pb) amplitude and
excess pressure integral (EPI).5–7 These parameters are important
because they have been shown to predict CVD incidence
independently of and more strongly than brachial BP.5–7 A few
studies have examined differences in aortic waveform parameters
between South Asian and European people,9–11 although these
studies did not assess parameters derived from wave separation6
or reservoir wave7 analyses. Another drawback is that some of
these studies investigated selected populations that either
excluded people with high BP10 or included only those with
BP-related morbidity (such as patients with heart failure11).
This restriction may result in poorly representative samples and
the inability to fully explore the relationship between ethnicity
and arterial function. In addition, we are not aware of any
studies that have evaluated differences between Polynesian and
European people.
Identifying determinants of arterial waveform measures helps to
deﬁne suitable strategies for improving arterial function. Three
possible determinants are alcohol consumption, smoking and
body mass index (BMI). A meta-analysis showed that alcohol
reduction decreased brachial BP among heavy drinkers,12
cigarette smoking has been shown to increase brachial BP,13
whereas smoking cessation has been demonstrated to reduce
brachial BP,14 and a meta-analysis showed that weight loss
reduced brachial BP.15 Although these intervention studies
demonstrate that reducing these three factors decreases brachial
BP, it is not known whether they are associated with various aortic
waveform parameters.
The ﬁrst objective of this study was to explore ethnic differences
in arterial waveform parameters between Europeans and people
from Polynesian and South Asian groups. We aimed to include a
wide range of arterial function measures, which may reveal
new ethnic variations. Our second objective was to examine
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associations between these parameters and alcohol consumption,
smoking and BMI.
MATERIALS AND METHODS
Participants
The present study is a baseline (cross-sectional) analysis of the ViDA (Vitamin
D Assessment) study, a randomised controlled trial of the health effects of
vitamin D supplementation in 5110 people. Participants were recruited from
patient registers of family doctors in Auckland. Inclusion criteria were men
and women aged 50–84 years and resident in Auckland at recruitment.
Participants were excluded if they had been diagnosed with a terminal
illness and/or in hospice care, intended to leave New Zealand during the
follow-up period, took vitamin D supplements (including cod liver oil) of
4600 IU per day, had a history of speciﬁc medical conditions (renal stones,
hypercalcaemia or conditions that can cause hypercalcaemia) and/or had a
baseline serum calcium 42.50 mmol l− 1. All baseline data were collected
between 2011 and 2012. Ethics approval was provided by the Ministry of
Health Multi-region Ethics committee. Written, informed consent was
obtained from each participant. Full details of the study design have been
published elsewhere.16
Measurements other than BP parameters
Demographic and lifestyle information, along with both history of diabetes
and CVD, were collected via questionnaires administered by trained
interviewers using a standardised protocol. Ethnicity was deﬁned by
self-identiﬁcation. Participants were initially categorised into four main
ethnic groups: Paciﬁc, Maori (both Polynesian groups), South Asian and
European/Other. Subsequently, we excluded 'Other' (non-European) people
from the 'European/Other' group as we aimed to have Europeans only in our
ethnic comparisons. Brachial BP has been found to vary between individual
Paciﬁc groups.3 Therefore, in the current study, the Paciﬁc group was further
broken down into speciﬁc categories of adequate sample sizes: Samoan,
Tongan and Other Paciﬁc (those from other Paciﬁc groups).
Alcohol consumption was assessed with the question, 'How often do you
have six or more drinks on one occasion?' Responses were categorised into
three groups: 'Never', '⩽ 1 per month' and 'weekly, daily or almost daily'.
Smoking was assessed by asking participants whether they had previously
smoked cigarettes, and whether they described themselves as ex-smokers
or current smokers. Responses were classiﬁed as 'non-smoker', 'ex-smoker'
or 'current smoker.' Participants were also asked the number of years since
quitting (for ex-smokers) and the number of cigarettes smoked per day.
To adjust for the effect of antihypertensive medications on the
waveform parameters, details of all prescriptions dispensed for participants
before and after their interview dates were collected from the Ministry of
Health. To determine that measured BP parameters have been inﬂuenced
by prescribed drugs, these medicines must have been taken just prior to
the interview. Therefore, antihypertensive use was deﬁned as the
prescription of an antihypertensive drug with days of supply that
encompassed the interview date.
Height was measured with a stadiometer to the nearest 0.1 cm, and
weight with digital scales to the nearest 0.1 kg. These measurements were
made without shoes and in light clothing. BMI was calculated as body weight
(kg) per height (m).2 A blood sample was taken, and collected aliquots were
stored at − 80 °C (−112 °F) and later measured for both serum total
cholesterol and HDL (high-density lipoprotein) cholesterol on a Siemens
Advia 2400 analyser (Siemens Healthcare Diagnostics, Erlangen, Germany).
Arterial waveform measures
After 15 min rest while sitting, BP (±1 mm Hg) was measured three times
with an Omron T9P oscillometric device (Omron Healthcare, Kyoto, Japan)
placed above the cubital fossa of the left arm and the mean of the two
closest measurements were used for analyses. Suprasystolic oscillometry
was carried out using a BP+ device (Uscom, Sydney, Australia) (formerly
known as a R6.5 cardiovascular monitor; Pulsecor, Auckland, New Zealand),
with an appropriately sized cuff positioned over the left upper arm.
The BP+ device has been shown to: (1) yield central systolic BPs that are
highly correlated with those assessed by catheter measurement at the
ascending aorta or aortic arch17 and, (2) measure central systolic BP
with good intratest and intertest reliability (intraclass correlation
coefﬁcients = 0.975 and 0.895, respectively).18 To improve the quality of
the waveforms used in analyses, we decided a priori to exclude readings
with a signal-to-noise ratio of o6 dB.
AIx, an index of arterial stiffness and wave reﬂection,19 was calculated
from the aortic pressure waveform using custom-written Matlab
software (Mathworks, Natick, MA, USA). A meta-analysis has shown AIx
to predict CV events.5
Wave separation analysis was used to separate the aortic pressure
waveform into forward and backward components.20 The amplitude of
backward pressure (Pb) was then calculated. Pb determined from this
technique has previously been shown to be similar to values obtained
using aortic ﬂow waveforms measured by Doppler ultrasound.21 Further,
independently of brachial BP, Pb has been shown to predict mortality22
and CV events.6
Aortic pressure was separated into reservoir and excess components
using custom-written Matlab software (Mathworks). Reservoir pressure was
calculated from pressure measurements, as described elsewhere.7 Peak
reservoir pressure was calculated as the amplitude of the reservoir
pressure waveform, which has been found to associate positively with the
risk of cardiovascular events independently of brachial BP.20 Excess
pressure was calculated as measured pressure minus reservoir pressure.23
The integral of the excess pressure waveforms (area under these
waveforms) over the cardiac cycle was used to calculate EPI. EPI measures
pressure that is associated with excess ventricular work and has been
shown to predict CV events independently of brachial SBP.7
Aortic pulse wave velocity (PWV) was calculated from validated
algorithms and derived PWV values have been shown to predict
CV events independently of brachial BP.24,25 PWV is a known predictor
of CV events, as demonstrated in a meta-analysis.26
Statistical analysis
Equality of variance across groups was checked with Levene’s test.
Inter-ethnic differences in participant characteristics were assessed with
analysis of variance (for continuous variables) and χ2-tests (for categorical
variables). Because of the positively skewed distribution of EPI, this was
converted to loge for analyses. Associations between independent
variables and arterial waveform parameters were examined by multivariate
linear regression, adjusting for covariates (listed in footnotes of tables) that
are determinants of BP variables. In separate models and in accordance
with research similar to ours,27 correction was made for pulse rate as
this inﬂuences the timing of reﬂected pressure waves and is a known
contributor to the shape of the aortic pressure waveform.28 The
signiﬁcance of main effects was examined with the F-test. Potential
interactions between sex and independent variables of these waveform
relationships were examined but as these were not statistically signiﬁcant,
we did not report sex-speciﬁc results. All analyses were performed using
SAS version 9.3 (SAS Institute, Cary, NC, USA) and statistical signiﬁcance
was set at Po0.05 (two-sided).
RESULTS
Participant characteristics
Table 1 shows the characteristics of the participants across the
ethnic groups. A total of 4798 people were included in
the analyses, although not all individuals answered questions so
that the total sample sizes for each of the categorical variables
varied slightly (maximum difference was n= 41 or o1% of the
total sample size, indicating a minimal loss of data). The
participants were 3961 Europeans, 321 Paciﬁc people, 266 Maori
and 250 South Asians. The composition of the Paciﬁc group was as
follows: 105 (33%) Samoan, 82 (26%) Tongan and 134 (42%) Other
Paciﬁc. The Other Paciﬁc group predominantly comprised Cook
Island Maori people (57%); the remainder being Niuean (25%),
Indigenous Fijian (12%), Tahitian (1%) and Other (5%).
As shown in Table 1, heavy alcohol consumption varied with
ethnicity (Po0.0001). Smoking prevalence (combined proportion
of ex-smokers and current smokers) was higher in Maori and lower
in South Asians with respect to Europeans (Po0.0001 for
relationship between smoking and ethnicity). Supplementary
analyses (not tabulated) revealed that, on average (median value),
ex-smokers quit smoking 28 years ago (interquartile range: 22
years), and the median number of cigarettes smoked per day
among current smokers was approximately just under 10 (58%
smoked ⩽ 10 per day). Compared with that of Europeans, BMI was
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higher in both Maori and Paciﬁc but lower in South Asians
(Po0.0001 for variation in BMI with ethnicity; Table 1).
Ethnic differences in arterial waveform parameters
Ethnic differences in arterial waveform parameters between
European and non-European groups are shown in Table 2.
Three sets of comparisons were made: those unadjusted for
brachial BP, adjusted for brachial SBP and adjusted for brachial
DBP. For the comparisons unadjusted for brachial BP, all
parameters varied with ethnicity (all P⩽ 0.042). Compared with
Europeans, Maori had higher levels of brachial SBP, brachial DBP,
aortic SBP, AIx, Pb, peak reservoir pressure and loge(EPI). Paciﬁc
people had higher levels of brachial SBP, brachial DBP, aortic SBP,
Pb, peak reservoir pressure, loge(EPI) and PWV with respect to
Europeans. Relative to Europeans, South Asians had higher levels
of AIx, Pb and loge(EPI).
For the comparisons adjusted for brachial SBP (Table 2),
all parameters varied with ethnicity (all P⩽ 0.004), except for
aortic SBP (P= 0.32) and peak reservoir pressure (P= 0.76).
At a given brachial SBP, compared with Europeans, South Asians
had higher levels of AIx, Pb and loge(EPI). Compared with
Europeans, at the same brachial SBP, Maori had lower PWV,
whereas Paciﬁc people had higher loge(EPI) but lower AIx
and PWV.
Similarly, at a ﬁxed brachial DBP, all waveform parameters
varied with ethnicity (all P⩽ 0.034; Table 2), except for PWV
(P= 0.50). For the same brachial DBP, South Asians had higher
levels of all waveform parameters relative to Europeans, except for
PWV. With respect to Europeans, Paciﬁc people had higher levels
of aortic SBP and loge(EPI), whereas Maori had higher levels of
loge(EPI).
We additionally examined differences in arterial waveform
parameters within Paciﬁc groups (having Other Paciﬁc
as the reference group; results not tabulated), adjusted
for age, sex, antihypertensive use, diabetes and CVD (plus pulse
rate for AIx). AIx varied across the Paciﬁc groups (P= 0.013),
with Other Paciﬁc people having higher AIx than both
Samoans (β= 3.6%, P= 0.011) and Tongans (β= 3.7%, P= 0.016).
There were no other differences among the Paciﬁc groups
(all P40.05).
Relationships between lifestyle factors and arterial waveform
parameters
Adjusted associations between modiﬁable factors and arterial
waveform parameters are illustrated in Table 3. Frequency of
heavy alcohol consumption had positive, dose-dependent
relationships with brachial SBP, aortic SBP, peak reservoir pressure
and PWV (all P⩽ 0.005). In each case, the beta-coefﬁcients for
people who consumed the most were more than double that of
those whose consumption was ⩽ 1 per month. AIx varied with
smoking (Po0.0001), with smokers having higher levels of this
variable than non-smokers. Speciﬁcally, AIx was higher in
ex-smokers than in non-smokers (β= 0.6%, P= 0.4) but
notably even more so in current smokers (β= 3.7%, Po0.0001).
BMI had positive relationships with all parameters except AIx and
Pb (all Po0.0001).
Pulse rate was positively associated with heavy alcohol
consumption (P= 0.004), smoking (Po0.0001) and BMI
(Po0.0001) (adjusted for age, sex, ethnicity, antihypertensive
use, diabetes and CVD). When the models for Table 3 were
also adjusted for pulse rate, the relationships were largely
unchanged. However, new associations were observed in a few
cases. That is, heavy alcohol consumption now had positive
relationships with Pb (P= 0.015) and loge(EPI) (P= 0.007),
whereas smokers (particularly current ones) had higher loge(EPI)
than non-smokers (P= 0.0002).
Impact of lifestyle and physiological variables on ethnic
differences
Next we examined the individual contributions of BMI, heavy
alcohol consumption and smoking to the ethnic differences
(controlling for sex, age, antihypertensive use, diabetes and CVD,
plus pulse rate for AIx; results not illustrated). Maori and Paciﬁc
Table 1. Characteristics of participants across ethnic groupsa
Variable Group European Paciﬁc Maori South Asian P-value
n 3961 321 266 250
Age (years) 67.6± 7.9 60.6± 7.5‡ 61.1± 8.0‡ 60.5± 7.7‡ o0.0001
Sex Male 2321 (59) 153 (48) 119 (45) 185 (74) o0.0001
Female 1640 (41) 168 (52) 147 (55) 65 (26)
Antihypertensive use No 2416 (61) 196 (61) 144 (54) 164 (66) 0.059
Yes 1545 (39) 125 (39) 122 (46) 86 (34)
Diabetes Yes 67 (2) 13 (4) 9 (3) 11 (4) 0.0005
No 3894 (98) 308 (96) 257 (97) 239 (96)
Cardiovascular disease Yes 495 (13) 32 (10) 30 (11) 29 (12) 0.55
No 3466 (88) 289 (90) 236 (89) 221 (88)
Heavy alcohol consumption Never 228 (6) 23 (7) 24 (9) 3 (1) o0.0001
(⩾6 drinks per occasion) ⩽ 1 per month 1037 (26) 58 (18) 91 (35) 26 (11)
Weekly, daily or almost daily 2669 (68) 237 (75) 146 (56) 215 (88)
Smoking Non-smoker 2024 (51) 172 (54) 76 (29) 170 (69) o0.0001
Ex-smoker 1728 (44) 106 (33) 140 (53) 69 (28)
Current smoker 201 (5) 42 (13) 48 (18) 9 (4)
Body mass index (kg m− 2) 27.9± 4.5 33.8± 6.1‡ 31.8± 6.6‡ 27.0± 4.1† o0.0001
Pulse rate (beats per minute) 62.9± 9.8 64.6± 10.2† 63.9± 11.0 68.0± 11.1‡ o0.0001
†Po0.01, ‡Po0.001 compared with European. aValues are sample size (column %) or mean± s.d.
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people had higher levels of arterial waveform parameters than
Europeans but, in most cases, these differences were markedly
attenuated (by between 11% and 72%) when BMI was controlled
for. Adjustment for heavy alcohol consumption had a
predominantly minor impact on these differences, changing these
by between 2% and 15%. Controlling for smoking resulted in
primarily small changes (by o1–12%) to the Paciﬁc, Maori and
South Asian regression coefﬁcients.
Following this, we evaluated the cumulative contributions of
several variables to the ethnic differences (Figure 1). As illustrated
in this ﬁgure, after controlling for age, sex, antihypertensive use,
diabetes and CVD, non-European people had higher levels of
arterial waveform parameters than Europeans in most cases.
Additional correction for all three lifestyle factors (heavy alcohol
consumption, smoking and BMI) notably reduced Maori and
Paciﬁc differences with European. But several ethnic differences
nevertheless persisted. We adjusted even further for the following
physiological variables: mean arterial pressure, pulse rate, height
and total:HDL cholesterol ratio. This reduced Maori and Paciﬁc
differences but Paciﬁc people still had higher loge(EPI) (β= 0.09,
indicating that EPI was e0.09 or 1.09 times higher; Po0.0001)
than Europeans. In contrast, after this adjustment, South Asians
had higher levels of aortic SBP (β= 2.2 mm Hg; Po0.0001),
AIx (β= 1.7%; P= 0.0028), Pb (β= 1.5 mm Hg; Po0.0001), peak
reservoir pressure (β= 1.3 mm Hg; P= 0.0053), loge(EPI) (β= 0.13,
indicating that EPI was e0.13 or 1.14 times higher; Po0.0001) and
PWV (β= 0.07; P= 0.028) with respect to Europeans.
DISCUSSION
Our results show that New Zealanders of non-European ethnicity
have higher levels of arterial waveform parameters than those of
European ethnicity. For the same brachial SBP or DBP, these
parameters varied with ethnicity, with South Asians particularly
having higher levels of these measures relative to Europeans.
Heavy alcohol consumption and BMI were positively and directly
related to nearly all waveform parameters, whereas smoking was
positively and directly associated with most of these. These
lifestyle factors together made large contributions to a number of
ethnic variations in these waveform parameters. But several ethnic
differences remained and, despite further accounting for mean
arterial pressure, pulse rate, height and total:HDL cholesterol ratio,
South Asians nonetheless had higher levels of all aortic waveform
parameters relative to Europeans.
The higher levels of brachial SBP we observed among Paciﬁc
people relative to Europeans concurs with ﬁndings in previous
studies.29,30 We extend this prior research by showing that these
ethnic groups additionally differ in aortic waveform parameters.
Other new ethnic variations were the higher AIx, Pb and EPI we
observed among South Asians with respect to Europeans. In line
with this, a relatively small study reported South Asians to have
higher stiffness index than Europeans.10
Another original ﬁnding was that, within the Paciﬁc group, there
were very few differences in aortic waveform parameters. In
accordance with our results, Samoan and Tongan adults have
been found to have similar brachial SBP.3 Despite this consistency,
we cannot rule out the possibility of intra-ethnic differences after
consideration of limitations with regard to sample size and
representativeness (discussed below).
Given that aortic waveform parameters varied with ethnicity
and that they predict cardiovascular events,5–7 they may mediate
disparities in CVD prevalence that exist between the ethnic groups
studied in this paper.1–4 Therefore, interventions directed at
improving arterial function in these populations might reduce
Table 2. Differences in arterial waveform parameters between European and non-European groupsa
Parameter Mean (s.e.) Difference compared with European (95% conﬁdence interval) P-value
European (n= 3961) Paciﬁc (n=321) Maori (n= 266) South Asian (n= 250)
Unadjusted for brachial BP
Brachial SBP (mm Hg) 137.4 (0.4) 5.4 (3.3, 7.6) 3.8 (1.5, 6.1) 0.1 (−2.3, 2.5) Po0.0001
Brachial DBP (mm Hg) 76.7 (0.2) 2.5 (1.4, 3.7) 2.6 (1.4, 3.9) − 1.1 (−2.4, 0.2) Po0.0001
Aortic SBP (mm Hg) 129.1 (0.4) 5.3 (3.2, 7.3) 3.9 (1.6, 6.1) 0.5 (−1.8, 2.9) Po0.0001
Augmentation index 29.1 (0.2) 0.1 (−1.0, 1.3) 1.8 (0.5, 3.0) 4.0 (2.7, 5.3) Po0.0001
Backward pressure amplitude (mm Hg) 20.8 (0.1) 1.0 (0.3, 1.6) 0.8 (0.0, 1.5) 0.9 (0.1, 1.6) P=0.003
Peak reservoir pressure (mm Hg) 119.9 (0.4) 4.4 (2.5, 6.3) 3.5 (1.5, 5.6) 0.3 (−1.9, 2.4) Po0.0001
loge(excess pressure integral (mm Hg.s)) 1.29 (0.01) 0.13 (0.09, 0.18) 0.07 (0.02, 0.11) 0.05 (0.00, 0.10) Po0.0001
Pulse wave velocity (m s− 1) 9.47 (0.02) 0.12 (0.03, 0.21) 0.07 (−0.02, 0.17) 0.00 (−0.10, 0.11) 0.042
Adjusted for brachial SBP
Aortic SBP (mm Hg) 130.7 (0.1) 0.1 (−0.4, 0.6) 0.3 (−0.2, 0.8) 0.4 (−0.1, 1.0) 0.32
Augmentation index 29.5 (0.2) −1.2 (−2.3, -0.2) 0.8 (−0.3, 2.0) 3.9 (2.8, 5.1) o0.0001
Backward pressure amplitude (mm Hg) 21.2 (0.09) − 0.3 (−0.8, 0.1) − 0.1 (−0.6, 0.4) 0.8 (0.3, 1.3) 0.004
Peak reservoir pressure (mm Hg) 121.3 (0.2) 0.0 (−0.8, 0.8) 0.5 (−0.4, 1.4) 0.2 (−0.7, 1.0) 0.76
loge(excess pressure integral (mm Hg.s)) 1.30 (0.01) 0.08 (0.04, 0.11) 0.03 (−0.01, 0.07) 0.05 (0.01, 0.09) o0.0001
Pulse wave velocity (m s− 1) 9.53 (0.01) −0.09 (−0.13, −0.05) −0.07 (−0.11, −0.03) 0.00 (−0.04, 0.04) o0.0001
Adjusted for brachial DBP
Aortic SBP (mm Hg) 131.0 (0.3) 2.0 (0.6, 3.4) 0.5 (−1.0, 2.1) 2.0 (0.4, 3.6) 0.007
Augmentation index 29.6 (0.2) − 0.8 (−1.8, 0.3) 0.8 (−0.4, 2.0) 4.7 (3.5, 5.9) o0.0001
Backward pressure amplitude (mm Hg) 21.0 (0.1) 0.6 (−0.0, 1.3) 0.4 (−0.3, 1.1) 1.0 (0.3, 1.7) 0.018
Peak reservoir pressure (mm Hg) 121.7 (0.2) 1.2 (-0.0, 2.4) 0.2 (−1.1, 1.5) 1.7 (0.3, 3.0) 0.034
loge(excess pressure integral (mm Hg.s)) 1.29 (0.01) 0.13 (0.09, 0.17) 0.07 (0.02, 0.11) 0.05 (0.00, 0.10) o0.0001
Pulse wave velocity (m s− 1) 9.52 (0.02) 0.02 (−0.06, 0.09) − 0.03 (−0.12, 0.05) 0.05 (−0.04, 0.14) 0.50
Abbreviations: BP=blood pressure; DBP=diastolic BP; SBP= systolic BP. aAll models were adjusted for age, sex, antihypertensive use, diabetes and
cardiovascular disease, plus pulse rate for augmentation index. Some models were further adjusted for brachial SBP or brachial DBP, as indicated in italics
above. P-values in table are for main effects. 95% conﬁdence intervals that do not encompass 0 and signiﬁcant main effects (Po0.05) for waveform variables
are in bold.
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these CVD disparities. Further, several of the waveform differences
were notable in size. For example, loge(EPI) was 0.13 higher in
Paciﬁc people than the reference group, indicating that EPI
was e0.13 or 1.14 times higher (a 14% difference) than among
Europeans. Although these results show that the ethnic variations
are potentially of clinical signiﬁcance, longitudinal analyses are
required to establish the contribution of these waveform
variations to ethnic differences in CVD incidence.
Previous studies have not examined whether, at a ﬁxed brachial
SBP or DBP, the ethnic groups we studied have different or
similar levels of aortic waveform parameters. Such comparisons
are of signiﬁcance because brachial BP is a widely used measure
of arterial function but various central BP parameters may be
more important predictors of cardiovascular morbidity and/or
mortality.5–7 Thus, we investigated how these parameters vary
with ethnicity at a given brachial SBP or DBP. Our ﬁnding that they
varied with ethnicity suggests that, across ethnic groups, it may be
difﬁcult to compare arterial function and its associated cardiovas-
cular risk using brachial BP alone.
Further, these results have implications for deﬁning hyperten-
sion or the risks associated with high BP. For example, at a given
brachial SBP, South Asians had higher parameter levels than
Europeans (Table 2). Therefore, for the same parameter level, they
would have lower brachial SBP. This indicates that the parameter
level at a hypertension threshold of 140 mm Hg of brachial SBP in
Europeans, for instance, would correspond to a lower brachial SBP
in South Asians. Therefore, to more accurately reﬂect these
parameters (but not necessarily risk of CVD), brachial SBP and DBP
cut-off points for deﬁning hypertension may need to be set at
different levels for the non-European groups we studied.
Our ﬁnding that heavy alcohol consumption and BMI were
positively and directly associated with brachial SBP concurs with
previous intervention studies.12–15 We extend this prior research
by showing that relationships additionally exist for several
non-brachial measures (Table 3). The positive association between
smoking and EPI (only after adjusting for pulse rate) is another
new ﬁnding and the higher AIx observed among current smokers
is consistent with a small intervention study in young adults.13
Compared with non-smokers, current smokers had 3.7 or 12%
higher AIx (Table 3); this percentage increment is relatively large
and potentially of clinical importance. Altogether, these results
support directing interventions at reducing heavy alcohol
consumption, smoking and BMI as means to reduce levels of
aortic waveform parameters.
Another original ﬁnding was the contribution of modiﬁable
factors to ethnic differences in these parameters. While heavy
alcohol consumption and smoking had modest contributions, BMI
accounted for a large part of the Paciﬁc and Maori differences. This
reﬂects the fact that BMI was strongly associated with waveform
parameters (Table 3) and was notably higher in both Paciﬁc and
Maori people relative to Europeans (Table 1). Thus, interventions
directed at reducing BMI in Polynesian people could be useful for
reducing ethnic disparities in the waveform parameters.
Some of the sample sizes for the ethnic minority groups are
comparatively small, but they are sufﬁcient to detect (with 90%
power and alpha=0.05) differences of ~ 0.2 s.d.s of waveform
parameters, which should be adequate to identify clinically mean-
ingful differences.5–7,20,22,26 Nonetheless, our study would be
enhanced by having larger sample sizes of non-European groups.
In particular, for the comparisons within Paciﬁc groups, larger sample
sizes may be required to detect possible differences. Although our
statistical models accounted for known confounders, they are
nevertheless subject to residual confounding from unobserved
factors. However, as demonstrated above, our results are consistent
with those of past research, including intervention studies. Although
the current study was population-based, the non-participation of
people decreases the external validity of our ﬁndings. However, this
does not necessarily lead to selection bias and, if it did, the effect
may have been reduced by adjustment for the covariates in our
models if they were related to non-participation.31 Further, with
selection bias being more of a problem when non-participation is
related to both exposure/independent and outcome variables,31 we
believe that any bias from the inclusion/exclusion criteria of our
study would not be a major issue since it is unlikely that they are
strongly related to both the independent and dependent variables
in our statistical models. Finally, the study sample was restricted to
adult patients of Auckland family doctors and thus our ability to
extrapolate ﬁndings more widely is limited.
In summary, we found new differences in arterial function
between European and non-European people, including measures
Table 3. Relationships between modiﬁable lifestyle factors and arterial waveform parametersa
Modiﬁable factor and level Arterial waveform parameter
Brachial systolic
blood pressure
(mm Hg)
Aortic systolic
blood pressure
(mm Hg)
Augmentation
index
Backward pressure
amplitude (mm Hg)
Peak reservoir
pressure
(mm Hg)
loge(excess pressure
integral (mm Hg s))
Pulse wave velocity
(m s− 1)
Heavy alcohol consumption
Neverb 139.3 (0.6) 131.0 (0.6) 30.4 (0.3) 21.34 (0.18) 121.6 (0.5) 1.34 9.50 (0.02)
⩽ 1 per monthc 1.7 (0.4, 2.9) 1.6 (0.4, 2.9) 0.5 (−0.2, 1.2) 0.41 (0.0, 0.82) 1.5 (0.4, 2.7) (0.01) 0.02
(−0.01, 0.04)
0.06 (0.01, 0.12)
Weekly, daily or almost
dailyc
4.2 (1.9, 6.5)
P=0.0003
3.9 (1.6, 6.1)
P=0.0005
1.0 (−0.3, 2.2)
P= 0.19
0.34 (−0.39, 1.08)
P= 0.13
3.2 (1.1, 5.2)
P=0.0013
0.03 (−0.01, 0.08)
P= 0.19
0.14 (0.04, 0.23)
P=0.0046
Smoking
Non-smokerb 139.1 (0.6) 130.8 (0.6) 29.9 (0.3) 21.32 (0.20) 121.6 (0.6) 1.34 (0.01) 9.50 (0.03)
Ex-smokerc 1.2 (0.1,2.3) 1.3 (0.2,2.3) 0.6 (0.0, 1.2) 0.23 (−0.11, 0.8 (−0.1,1.8) 0.02 (−0.00, 0.04) 0.05 (0.01,0.10)
Current smokerc 1.3 (−0.9, 3.5)
P= 0.07
1.1 (−1.0, 3.3)
P= 0.05
3.7 (2.5, 4.9)
Po0.0001
0.58) 0.10 (−0.61, 0.81)
P= 0.42
0.2 (−1.8, 2.2)
P= 0.23
0.04 (−0.01, 0.08)
P= 0.08
− 0.01 (−0.10, 0.08)
P= 0.070
Body mass index (kg m− 2) 0.57 (0.46, 0.68)
Po0.0001
0.51 (0.40, 0.62)
Po0.0001
−0.2 (−0.3, − 0.2)
Po0.0001
0.03 (−0.01, 0.06)
P= 0.17
0.5 (0.4, 0.6)
Po0.0001
0.005 (0.002, 0.007)
Po0.0001
0.02 (0.01, 0.02)
Po0.0001
aAdjusted for age, sex, ethnicity, antihypertensive use, diabetes and cardiovascular disease, plus pulse rate for augmentation index; P-values listed are for main
effects. bReference group—values are adjusted means (95% conﬁdence intervals). cValues are differences (increments) in adjusted means (95% conﬁdence
intervals); *Po0.05, †Po0.01, ‡Po0.001 compared with reference group (for categorical variables) or for the slope (for BMI); 95% conﬁdence intervals that do
not encompass 0 and signiﬁcant main effects (Po0.05) for waveform variables are in bold.
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Pacific
Brachial SBP
(mmHg)
Aortic SBP
(mmHg)
Augmentation
index
Backward pressure
amplitude (mmHg)
Peak reservoir
pressure (mmHg)
loge(excess pressure
integral (mmHg.s))
Pulse wave
velocity (m/s)
A B A B A B
A B C A B C A B C
A B C A B C A B C
A B C A B C A B C
A B C A B C A B C
A B C A B C A B C
A B C A B C A B C
South AsianMaori
Figure 1. Ethnic differences, compared with Europeans, in arterial waveform parameters. Bar A covariates are age, sex, antihypertensive use,
diabetes and cardiovascular disease, plus pulse rate for augmentation index. Bar B covariates are bar A covariates plus heavy alcohol
consumption, smoking and BMI. Bar C covariates are bar B covariates plus mean arterial pressure, pulse rate, height and total:HDL cholesterol
ratio. Grey and white bars represent signiﬁcant and non-signiﬁcant differences, respectively. Error bars represent the upper values of the 95%
conﬁdence intervals.
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of wave reﬂection and excess cardiac work. Several of these,
particularly South Asian differences, remained unexplained as
they were independent of numerous BP-related factors
including demographics, lifestyle and physiological variables.
As these varied in line with recognised differences in CVD
prevalence between these populations and several were notable
in size, the observed variations are potentially important
mediators of ethnic CVD disparities. Across ethnic groups, at the
same brachial BP, aortic waveform parameters vary with ethnicity,
suggesting that the former has limited usefulness in capturing
ethnic variations of these parameters. In other words, brachial BP
cannot act as a surrogate for these parameters and ethnic
differences in the latter will be better monitored by quantifying
these parameters (using monitors such as the BP+device used in
the current study). Finally, heavy alcohol consumption, smoking
and BMI were positively and directly associated with these
parameters, supporting interventions aimed at reducing these
three risk factors as strategies to improve arterial function.
Reducing BMI may be a particularly important strategy as this
modiﬁable factor made a large contribution to ethnic differences
in the waveform parameters.
What is known about this topic?
● While it is unknown whether central blood pressure (BP)
parameters differ between Polynesians and Europeans, some of
these have been shown to vary across South Asian and European
groups.
● But such data are scarce, may be based on poorly representative
samples and did not investigate some new such measures. Further,
knowledge of whether ethnic differences are independent of
brachial BP is lacking.
● Reducing alcohol consumption, cigarette smoking and BMI decrease
brachial BP but their associations with various central BP parameters
are unknown.
What this study adds?
● In a population-based sample, compared with Europeans,
Polynesians and South Asians had higher, multivariate-adjusted
levels of aortic systolic BP, augmentation index and novel central
BP variables: Pb amplitude, peak reservoir pressure and EPI.
● Many of these differences remained after adjustment for brachial
BP, suggesting that central BP parameters may have increased
usefulness in capturing ethnic variations in cardiovascular risk. South
Asian differences remained unexplained as they were independent
of numerous BP-related factors including demographics, lifestyle
and physiological variables.
● Heavy alcohol consumption and BMI were positively related to
nearly all BP parameters, whereas smoking was positively associated
with most of these. Several but not all Maori and Paciﬁc differences
in these BP parameters were largely accounted for by ethnic
variations in BMI.
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